For InMed Pharmaceuticals, Inc. (CSE: IN) (OTC: IMLFF) (IMLFF Profile), a preclinical-stage biopharmaceutical company at the vanguard of cannabinoid -based bio-pharmacology, market awareness of the company’s drug development pipeline and biosynthesis technology has led to gains of more than … Read More
The post Biotech Market Banking on Big Cannabis Returns appeared first on Dagga Magazine.